From your experience scaling from an RCT to more than 7,000 clinics, what evidence would you want to see before investing in a smaller Nigerian organisation proposing a community-based intervention—strong outcome data, operational capacity, cost-effectiveness, government relationships, or something else?

As New Incentives explores whether its model can work in lower-density or differently constrained settings, what characteristics would you look for in a local Nigerian organisation interested in serving as an implementation or pilot partner? Would you consider partnering with community-based health organisations to test adaptations of the model in underserved communities or displaced populations?